Thymosin alpha-1 / LL-37 stack: what's in it
- 2 sources
- How we source
- We don't sell peptides. We never link "research use only" sellers.
The short answer
Thymosin alpha-1 / LL-37 stack combines Thymosin alpha-1 and LL-37.
What it is
Immune stack.
What people look into
Skin and hair, aging
Results for one compound don't tell you what the two do together.
The parts
Approved outside the US
Not FDA-approved
Regulatory status by component
Not FDA-approved How we label status
- As of October 4, 2026, Thymosin alpha-1 is not FDA-approved for any use and is not on FDA's 503A bulks list. It is approved in Italy. See Thymosin alpha-1 in the Index →
- As of October 4, 2026, LL-37 (cathelicidin) is not FDA-approved for any use and is not on FDA's 503A bulks list. See LL-37 (cathelicidin) in the Index →
Status as of October 4, 2026
- As a combination
- No category as a combination (see components)
Get updates on Thymosin alpha-1 / LL-37 stack
The research on Thymosin alpha-1 / LL-37 stack
Key facts
Also known as: ta1 ll-37, immune resilience stack
- Parts
- Thymosin alpha-1 and LL-37 (cathelicidin)
- Route
- injectable
References
Status sources
Sources as of October 4, 2026
What this doesn’t establish
Results for one compound don't tell you what the two do together.